U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

RWE Strategy Lead Respiratory - US

Clinical Research OperationsUpdated on Nov 14
Full-time$184k - $265.7k

About the Job

Requirements

  • An advanced degree in life sciences, medicine, epidemiology, statistics, or a related discipline is required.
  • At least eight years of pharmaceutical industry experience is required, ideally within respiratory medicine or immunology.
  • Strong expertise in epidemiology, outcomes research, clinical development, regulation, and market access is required.
  • Experience developing integrated evidence strategies across multiple internal and external stakeholder groups is required.
  • Proven matrix leadership, influencing, mentoring, and cross-functional collaboration capabilities are required.
  • Excellent English communication and scientific writing skills, with strong quantitative expertise, are required.

Responsibilities

  • Develop integrated real-world evidence strategies supporting respiratory assets throughout their lifecycle.
  • Translate stakeholder research questions into impactful data, registry, and evidence-generation plans.
  • Lead real-world evidence studies, ensuring quality, governance, timelines, and budget adherence.
  • Collaborate across functions to align evidence priorities and resolve competing stakeholder needs.
  • Build relationships with external experts, research partners, and healthcare decision-makers.
  • Mentor evidence-generation professionals and support capability development across the global function.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs